Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability.

Schäfer R, Kehlbach R, Müller M, Bantleon R, Kluba T, Ayturan M, Siegel G, Wolburg H, Northoff H, Dietz K, Claussen CD, Wiskirchen J.

Cytotherapy. 2009;11(1):68-78. doi: 10.1080/14653240802666043.

PMID:
19191056
2.

Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide.

Schäfer R, Kehlbach R, Wiskirchen J, Bantleon R, Pintaske J, Brehm BR, Gerber A, Wolburg H, Claussen CD, Northoff H.

Radiology. 2007 Aug;244(2):514-23. Epub 2007 Jun 11.

PMID:
17562811
3.

Functional investigations on human mesenchymal stem cells exposed to magnetic fields and labeled with clinically approved iron nanoparticles.

Schäfer R, Bantleon R, Kehlbach R, Siegel G, Wiskirchen J, Wolburg H, Kluba T, Eibofner F, Northoff H, Claussen CD, Schlemmer HP.

BMC Cell Biol. 2010 Apr 6;11:22. doi: 10.1186/1471-2121-11-22.

4.

Study of apoptosis in labeled mesenchymal stem cells with superparamagnetic iron oxide using neutral comet assay.

Omidkhoda A, Mozdarani H, Movasaghpoor A, Fatholah AA.

Toxicol In Vitro. 2007 Sep;21(6):1191-6. Epub 2007 Mar 30.

PMID:
17493781
5.

Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells.

Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA.

NMR Biomed. 2005 Dec;18(8):553-9.

PMID:
16229060
6.

Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis.

Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW.

NMR Biomed. 2004 Nov;17(7):513-7.

PMID:
15526348
7.

Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo.

Farrell E, Wielopolski P, Pavljasevic P, van Tiel S, Jahr H, Verhaar J, Weinans H, Krestin G, O'Brien FJ, van Osch G, Bernsen M.

Biochem Biophys Res Commun. 2008 May 16;369(4):1076-81. doi: 10.1016/j.bbrc.2008.02.159. Epub 2008 Mar 10.

PMID:
18336785
8.

[Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T].

Ittrich H, Lange C, Dahnke H, Zander AR, Adam G, Nolte-Ernsting C.

Rofo. 2005 Aug;177(8):1151-63. German.

PMID:
16021549
9.

Superparamagnetic iron oxide does not affect the viability and function of adipose-derived stem cells, and superparamagnetic iron oxide-enhanced magnetic resonance imaging identifies viable cells.

Wang L, Deng J, Wang J, Xiang B, Yang T, Gruwel M, Kashour T, Tomanek B, Summer R, Freed D, Jassal DS, Dai G, Glogowski M, Deslauriers R, Arora RC, Tian G.

Magn Reson Imaging. 2009 Jan;27(1):108-19. doi: 10.1016/j.mri.2008.05.013. Epub 2008 Jul 26.

PMID:
18657922
10.

Ultrastructural characterization of mesenchymal stromal cells labeled with ultrasmall superparamagnetic iron-oxide nanoparticles for clinical tracking studies.

Hansen L, Hansen AB, Mathiasen AB, Ng M, Bhakoo K, Ekblond A, Kastrup J, Friis T.

Scand J Clin Lab Invest. 2014 Aug;74(5):437-46. doi: 10.3109/00365513.2014.900698. Epub 2014 Apr 15.

PMID:
24734781
11.

Dose-response of superparamagnetic iron oxide labeling on mesenchymal stem cells chondrogenic differentiation: a multi-scale in vitro study.

Roeder E, Henrionnet C, Goebel JC, Gambier N, Beuf O, Grenier D, Chen B, Vuissoz PA, Gillet P, Pinzano A.

PLoS One. 2014 May 30;9(5):e98451. doi: 10.1371/journal.pone.0098451. eCollection 2014.

12.

Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides.

Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF.

Blood. 2004 Nov 15;104(10):3410-2; author reply 3412-3. No abstract available. Erratum in: Blood. 2005 Jan 15;105(2):473.

13.

In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T.

Ittrich H, Lange C, Tögel F, Zander AR, Dahnke H, Westenfelder C, Adam G, Nolte-Ernsting C.

J Magn Reson Imaging. 2007 Jun;25(6):1179-91.

PMID:
17520738
14.
15.

Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B™.

Addicott B, Willman M, Rodriguez J, Padgett K, Han D, Berman D, Hare JM, Kenyon NS.

Contrast Media Mol Imaging. 2011 Jan-Feb;6(1):7-18. doi: 10.1002/cmmi.396. Epub 2010 Aug 5.

16.

Assessment of biological characteristics of mesenchymal stem cells labeled with superparamagnetic iron oxide particles in vitro.

Sun JH, Zhang YL, Qian SP, Yu XB, Xie HY, Zhou L, Zheng SS.

Mol Med Rep. 2012 Feb;5(2):317-20. doi: 10.3892/mmr.2011.637. Epub 2011 Oct 18.

PMID:
22011913
17.

In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver.

Bos C, Delmas Y, Desmoulière A, Solanilla A, Hauger O, Grosset C, Dubus I, Ivanovic Z, Rosenbaum J, Charbord P, Combe C, Bulte JW, Moonen CT, Ripoche J, Grenier N.

Radiology. 2004 Dec;233(3):781-9. Epub 2004 Oct 14.

PMID:
15486216
18.

Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function.

Oude Engberink RD, van der Pol SM, Döpp EA, de Vries HE, Blezer EL.

Radiology. 2007 May;243(2):467-74.

PMID:
17456871
19.

Clinically translatable cell tracking and quantification by MRI in cartilage repair using superparamagnetic iron oxides.

van Buul GM, Kotek G, Wielopolski PA, Farrell E, Bos PK, Weinans H, Grohnert AU, Jahr H, Verhaar JA, Krestin GP, van Osch GJ, Bernsen MR.

PLoS One. 2011 Feb 23;6(2):e17001. doi: 10.1371/journal.pone.0017001.

20.

Efficient In vitro labeling rabbit bone marrow-derived mesenchymal stem cells with SPIO and differentiating into neural-like cells.

Zhang R, Li J, Li J, Xie J.

Mol Cells. 2014 Sep;37(9):650-5. doi: 10.14348/molcells.2014.0010. Epub 2014 Sep 18.

Supplemental Content

Support Center